| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
ARTICLES |
Nuclear Medicine Research Laboratory, Veterans Administration Medical Center (R.R.C.), San Francisco, California; the Department of Pharmaceutical Sciences, University of Brasilia (L.A.S., R.C.J.R.), Brasilia, DF Brazil; University of California (S.W.P.), Davis, California 95817; and the Metabolic Research Unit (J.D.B.), Gastroenterology Division (B.F.S., N.L.), and Liver Center (R.R.C., B.F.S., N.L.), Department of Medicine, University of California, San Francisco, California 94143-0538
Address all correspondence and requests for reprints to: Dr. Noureddine Lomri, Gastroenterology Division, University of California, 513 Parnassus Avenue, S-357, P.O. Box 0538, San Francisco, California 94143. E-mail: nlomri{at}itsa.ucsf.edu
Export of L-T3 out of the cell is one factor
governing the cellular T3 content and response. We
previously observed in liver-derived cells that T3 export
was inhibited by verapamil, suggesting that it is due to either
ATP-binding cassette/multidrug resistance (MDR1/mdr1b) or multidrug
resistance-related (MRP1/mrp1) proteins. To test this hypothesis we
measured T3 export in FRTL-5, NIH-3T3, and rat hepatoma
(HTC) cells that varied in expression of these proteins. FRTL-5 and
NIH-3T3 cells were found to contain a T3 efflux mechanism
that is verapamil inhibitable, saturable, and stereospecific. By
contrast, T3 efflux in HTC cells was slow and unaffected by
verapamil. Neither FRTL-5 nor NIH-3T3 cells express mdr1b, but all
three cell types express mrp1, as assessed by immunoblotting.
Overexpression of MDR1 in NIH-3T3 cells did not enhance
verapamil-inhibitable T3 efflux. Photoaffinity labeling of
FRTL-5 and NIH-3T3 cells with
[125I]L-T3 revealed a labeled 90-
to 100-kDa protein that was not present in HTC cells. Verapamil and
excess nonradioactive L-T3, but not
D-T3, inhibited labeling of this protein. The
lack of correlation between T3 efflux and MDR1 and mrp1
expression and the finding of a photoaffinity-labeled putative
transport protein smaller than MDR1 or mrp1 protein (
170 kDa)
suggest that a novel protein is involved in the transport of
T3 out of cells.
This article has been cited by other articles:
![]() |
W. E. Visser, E. C. H. Friesema, and T. J. Visser Transport of Thyroxine and 3,3',5-Triiodothyronine in Human Umbilical Vein Endothelial Cells Endocrinology, March 1, 2009; 150(3): 1552 - 1557. [Abstract] [Full Text] [PDF] |
||||
![]() |
A M Mitchell, M Tom, and R H Mortimer Thyroid hormone export from cells: contribution of P-glycoprotein J. Endocrinol., April 1, 2005; 185(1): 93 - 98. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. A. R. Neves, R. R. Cavalieri, L. A. Simeoni, D. G. Gardner, J. D. Baxter, B. F. Scharschmidt, N. Lomri, and R. C. J. Ribeiro Thyroid Hormone Export Varies among Primary Cells and Appears to Differ from Hormone Uptake Endocrinology, February 1, 2002; 143(2): 476 - 483. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Hennemann, R. Docter, E. C. H. Friesema, M. de Jong, E. P. Krenning, and T. J. Visser Plasma Membrane Transport of Thyroid Hormones and Its Role in Thyroid Hormone Metabolism and Bioavailability Endocr. Rev., August 1, 2001; 22(4): 451 - 476. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |